2 results
Search Results
Now showing 1 - 2 of 2
Article Simultaneous Removal of Setazol Navy Blue and Cr(vi) by Mixed Microbial Culture Isolated From the Çubuk Stream(Springer int Publ Ag, 2024) Gunduz, A. Irem; Erkoc, Esra; Korkmaz, Filiz; Kilic, Nur KocberberWater samples taken from the & Ccedil;ubuk Stream (Ankara, Turkey) were inoculated into nutrient broth media containing Setazol Navy Blue SBG (SNB), an organic pollutant, and heavy metal Cr(VI), an inorganic pollutant, to obtain a pollutant-resistant mixed microbial culture. Experiments were conducted with this culture to remove SNB and heavy metal. The optimum conditions, where the mixed bacterial culture removed the pollutants most effectively, were determined, showing that the highest capacity for removal took place at pH 8 with removal percentages 96.3% for Cr(VI) and 78.5% for SNB. In media with 50.4 mg/L SNB and 9.7 mg/L Cr(VI), the SNB removal was 87.3%, and the Cr(VI) removal was 96.6% at the end of the 7-day incubation period. The highest removal was observed with a biomass concentration of 8% (v/v) of mixed culture [50 mg/L SNB dye+25 mg/L Cr(VI)]. The removal was 100% for both Cr(VI) and the SNB dye. The bacteria with the highest removal were isolated and identified using 16S rDNA gene sequence analysis as Microbacterium oxydans and Leucobacter aridicollis. The role of various functional groups and the structures of the microorganisms that might be involved in the removal mechanisms were discussed using their FTIR spectra. This report is the first study that investigates a mixed bacterial culture and pure cultures (M. oxydans and L. aridicollis) isolated from that mixed culture, removing both SNB and Cr(VI) simultaneously.Article Citation - WoS: 31Citation - Scopus: 30Interaction of a Novel Platinum Drug With Bovine Serum Albumin: Ftir and Uv-Vis Spectroscopy Analysis(Royal Soc Chemistry, 2015) Korkmaz, Filiz; Erdogan, Deniz Altunoz; Ozalp-Yaman, SenizPlatinum complexes have proven to be very effective in cancer treatment. However, severe side effects of these drugs have lead scientists to pursue new platinum complex derivatives. A novel blue platinum compound, called Platinum-Blue (Pt-Blue), is one of the promising candidate platinum compounds to be used for tumor treatment. In this study, the interaction of Pt-Blue with bovine serum albumin (BSA) has been investigated using UV-Vis and FTIR spectroscopy. One of the findings is that the drug-protein interaction type depends on the drug concentration. Though Pt-Blue is attached to the surface of BSA at high concentrations, it interacts with a hydrophobic region of the protein at low concentrations with a binding constant of 1.93 x 10(5) M-1. Spectroscopic results indicate the hydrophobic docking position to be around Trp 213 in domain II, which is surrounded by a number of Asp and Glu. During this interaction, helices such as helix-10, helix-18, helix-19 and helix-24 change orientation and/or partially unfold to make room for the compound. Binding constants at high and low concentrations of Pt-Blue are determined using UV-Vis spectroscopy, which are found to be comparable to cisplatin. FTIR spectroscopy also reveals that the interaction between Pt-Blue and BSA is noncovalent, which makes the candidate drug favorable because it is available for DNA binding while being carried by albumin.
